Dr. Man received his medical and MS degrees in China, his Ph.D. in Cell Biology, and his postdoctoral training in Cancer Biology in the USA. He served as the Director of Gynecological and Breast Research Laboratory of Armed Forces Institute of Pathology and American Registry of Pathology, the Director of the Research Laboratory of Bon Secours Cancer Institute, and the Co-Director of Laboratory of Proteomics and Protein Sciences of Veterans Affair Health System. He also served as Associated Editor-in-chief of Cancer Detection---Prevention, and Cancer Epidemiology. Currently, he serves as the Editors-in-chief of Journal of Cancer, the Chairman of Board Directors of International Union for Difficult-to-treat-Diseases, and a grant review panel member for a number of national and international cancer research-related organizations.
Dr. Man has authored and co-authored about 300 published abstracts, manuscripts, book chapters, and novel protocols for molecular and immunohistochemical assays. He is the recipient and co-recipient of over 20-nationally-funded research grants, and inventor and co-inventor of about 20-patents. Currently, Dr. Man’s research interests are focused primarily on the mechanisms of cancer invasion and metastasis. He is the originator of novel hypotheses for both cancer invasion and cancer metastasis. His ideas have increasingly gained recognition, and he has been invited to present his views by colleagues in National Institutes of Health, Dana-Farber Cancer Institute of Harvard Medical School, Johns Hopkins University, UCLA, Barbara Ann Karmanos Cancer Institute, Florida State University, and other international prestigious Institutions. His hypothesis of cancer invasion has been recognized as “more compatible with existing experimental evidence than the traditional protoelytic enzyme theory.